MORGAN STANLEY PLC/PUT/ECKERT & ZIEGLER/35/0.1/20.09.24 Share Price

Warrant

DE000ME4ZX83

Market Closed - Börse Stuttgart 17:09:45 20/06/2024 BST
0.119 EUR -9.85% Intraday chart for MORGAN STANLEY PLC/PUT/ECKERT & ZIEGLER/35/0.1/20.09.24
Current month-13.77%
1 month-30.00%
Date Price Change
20/06/24 0.119 -9.85%
19/06/24 0.132 -3.65%
18/06/24 0.137 +4.58%
17/06/24 0.131 -3.68%
14/06/24 0.136 +2.26%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 05:09 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ECKERT & ZIEGLER SE
Issuer Morgan Stanley
WKN ME4ZX8
ISINDE000ME4ZX83
Date issued 11/12/2023
Strike 35
Maturity 20/09/2024 (92 Days)
Parity 10 : 1
Emission price 0.45
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.52
Lowest since issue 0.118
Delta-0.16x
Omega 5.177
Premium26.1x
Gearing33.09x
Moneyness 0.7692
Difference Strike -10.5
Difference Strike %-30.00%
Spread 0.041
Spread %25.95%
Theoretical value 0.1375
Implied Volatility 63.18 %
Total Loss Probability 75.60 %
Intrinsic value 0.000000
Present value 0.1375
Break even 33.63 €
Theta-0.01x
Vega0.01x
Rho-0x

Company Profile

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Sector
-
More about the company

Ratings for Eckert & Ziegler SE

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eckert & Ziegler SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.5 EUR
Average target price
62.5 EUR
Spread / Average Target
+37.36%
Consensus